PT 141 Peptide: Bremelanotide Melanocortin Receptor Agonist Research Compound

Global Peptides supplies research grade PT-141 to laboratories across Australia, supporting studies into melanocortin receptor signalling and the central pathways linked to neuroendocrine and behavioural responses.

PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide derived from the structure of alpha melanocyte stimulating hormone. It acts as an agonist at melanocortin receptors, with MC4R the receptor most often discussed, and is studied in models that explore receptor mediated signalling within the central nervous system, distinct from pathways that act on blood vessels.

Each batch is produced under controlled manufacturing conditions and undergoes independent laboratory verification, supporting consistent, repeatable results across analytical testing. A Certificate of Analysis is available on request for every order.

What is PT-141?

Researchers often ask how this compound is classified and which receptor pathways it engages in experimental systems.

PT-141 belongs to the melanocortin receptor agonist family. Its activity is examined in connection with MC4R and related receptors, which are involved in arousal and motivational signalling, mood related pathways and hormone linked neural activity.

Bremelanotide is also the active ingredient in a prescription medicine approved in the United States for a specific indication and supplied under medical supervision. The research material supplied by Global Peptides is entirely separate from that product and is not intended for any human or animal use.

Research Areas Explored With PT-141

Within controlled laboratory settings, research connected to PT-141 commonly looks at areas such as:

• Melanocortin receptor activation pathways
• MC4R signalling and receptor binding studies
• Central nervous system signalling models
• Neuroendocrine response mechanisms
• Motivational and behavioural pathway research
• Mood related signalling investigations

These points reflect laboratory observation only and are not intended as claims about therapeutic outcomes.

Research Areas of Interest

• Melanocortin receptor pharmacology
• MC4R pathway research
• Neuroendocrine system regulation
• Comparative research against related melanocortin compounds

Product Information

• Compound: PT-141 (Bremelanotide)
• Classification: Cyclic heptapeptide melanocortin receptor agonist
• Receptor target: MC4R and related melanocortin receptors
• Form: Lyophilised powder
• Purity level: 98% or above (HPLC verified)
• Testing: Independent third-party laboratory verification, CoA available on request

Why Researchers Reference PT-141

Laboratories studying melanocortin signalling frequently reference this compound for its central receptor profile, and comparing PT-141 peptides against other melanocortin agonists helps clarify how receptor selectivity shapes downstream pathway activity.

Researchers comparing options across related compounds can explore the full peptides category for additional research materials.

Buy PT 141 Australia

Laboratories can source PT-141 Australia wide through Global Peptides, supported by transparent documentation and confirmed purity levels for every batch.

Researchers searching for Bremelanotide Australia stock can rely on consistent quality control and batch specific Certificates of Analysis with every order.

Researchers who buy PT 141 peptide for laboratory projects gain access to HPLC and LC-MS verification and secure ordering processes designed for research institutions.

Global Peptides offers fast nationwide shipping and dedicated support for research enquiries, and researchers can browse our catalog to view other research compounds available alongside PT-141.

Research Use Only

This compound is supplied strictly for laboratory and scientific research purposes and is not approved for consumption, therapeutic use or clinical application outside of a qualified research setting.